Furthermore, S100A8-treated macrophages cannot promote T cell proliferation in vitro and can suppress the cytotoxic function of tumor-primed T cells in vivo through PD-L1 (Li et al., 2020). This evidence concerns the gene S100A8 and neoplasm.